An injured Kurdish defender recounts fighting against the jihadists, including seeing decapitated villagers and evidence of drug use
Companies have sweeping discretion to effectively regulate what their workers do outside of work, including running for elected office
Some reformers of Social Security focus on squeezing more money out of working Americans and their employers. Why not focus on incentives to keep older Americans working?
The health network has genetic data on more than 210,000 members
New tapes provide an unprecedented look into how bank examiners defer to the banks they are supposed to police
A handful of companies in the U.S. still paint large-scale, photorealistic advertisements
A developer builds an over-the-top mansion and waits for a buyer
MBAs will explore the artist and national treasure's marketing strategy in an upcoming case study
To address environmental and quality of life concerns, Bruges has approved a pipeline connecting De Halve Maan brewery to its bottling facility
Founders: Dr. Mark Chandler and Craig Benson (The company was formed in 1998 as a wholly owned subsidiary of Luminex Corp. (LMNX) and subsequently spun off in 2002 as a private management-owned entity.)
VC Investment over the last four quarters: $25 million
With 95 employees worldwide, Rules-Based Medicine, a biomarker testing company, is actively developing diagnostic tests to detect the presence of complex diseases and conditions in the areas of neuropsychiatry, nephrology, immunology, and cardiology. The company is also developing what it calls the first fully closed reproducible whole-blood culture system. Despite the recession, Rules-Based Medicine's founders remain optimistic about its prospects and those of its peers that promote efficiency and cost savings for drug development and diagnostics customers.
Key to startup success: "We took a customer-focused approach to biotechnology, which drove our decision to commit resources to developing much needed comprehensive biomarker content. ... Our customers have essentially directed and funded our R&D since inception."